Reports

Industry Research Reports

Home > Reports > Service & Software > Personalized Medicine (PM) Solution- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Personalized Medicine (PM) Solution- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Personalized Medicine (PM) Solution- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-02-21

Pages: 166 Pages

Report ld: 4142554

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global market for Personalized Medicine (PM) Solution was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Personalized Medicine (PM) Solution, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Personalized Medicine (PM) Solution by region & country, by Type, and by Application.

The Personalized Medicine (PM) Solution market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Medicine (PM) Solution.

MARKET SEGMENTATION

By Company

  • 2bPrecise
  • OneOme
  • TIGAR Health- IR2Dx
  • Kailos Genetics
  • Syapse Inc
  • Karius
  • Astarte Medical
  • Fabric Genomics, INC.
  • Orion Health
  • 2B Precise
  • Fabric Genomics
  • Pfizer
  • Gene 42
  • IBM Watson Health
  • Philips Healthcare
  • Medtronic
  • Nanthealth
  • Navican
  • N-of-One
  • PierianDx
  • Sunquest Information System
  • Tempus
  • Novartis
  • Translational Software
  • Biocrates Life Sciences AG
  • Nanostring Technologies
  • Thermo Fisher Scientific
  • Quest Diagnostics Incorporated

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Personalized Diagnostics
  • Personalized Therapies
  • Personalized Nutrition & Wellness

Segment by Application

  • Oncology
  • Neurosciences
  • Immunology
  • Respiratory
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 2: Detailed analysis of Personalized Medicine (PM) Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 5: Revenue of Personalized Medicine (PM) Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

marn_i1

Chapter 6: Revenue of Personalized Medicine (PM) Solution in country level. It provides sigmate data by Type, and by Application for each country/region.

marn_i1

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

marn_i1

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Personalized Medicine (PM) Solution Product Introduction

1.2 Global Personalized Medicine (PM) Solution Market Size Forecast (2020-2031)

1.3 Personalized Medicine (PM) Solution Market Trends & Drivers

1.3.1 Personalized Medicine (PM) Solution Industry Trends

1.3.2 Personalized Medicine (PM) Solution Market Drivers & Opportunity

1.3.3 Personalized Medicine (PM) Solution Market Challenges

1.3.4 Personalized Medicine (PM) Solution Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Competitive Analysis by Company

2.1 Global Personalized Medicine (PM) Solution Players Revenue Ranking (2024)

2.2 Global Personalized Medicine (PM) Solution Revenue by Company (2020-2025)

2.3 Key Companies Personalized Medicine (PM) Solution Manufacturing Base Distribution and Headquarters

2.4 Key Companies Personalized Medicine (PM) Solution Product Offered

2.5 Key Companies Time to Begin Mass Production of Personalized Medicine (PM) Solution

2.6 Personalized Medicine (PM) Solution Market Competitive Analysis

2.6.1 Personalized Medicine (PM) Solution Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Personalized Medicine (PM) Solution Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine (PM) Solution as of 2024)

2.7 Mergers & Acquisitions, Expansion

muLu

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Personalized Diagnostics

3.1.2 Personalized Therapies

3.1.3 Personalized Nutrition & Wellness

3.2 Global Personalized Medicine (PM) Solution Sales Value by Type

3.2.1 Global Personalized Medicine (PM) Solution Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Personalized Medicine (PM) Solution Sales Value, by Type (2020-2031)

3.2.3 Global Personalized Medicine (PM) Solution Sales Value, by Type (%) (2020-2031)

muLu

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Oncology

4.1.2 Neurosciences

4.1.3 Immunology

4.1.4 Respiratory

4.1.5 Others

4.2 Global Personalized Medicine (PM) Solution Sales Value by Application

4.2.1 Global Personalized Medicine (PM) Solution Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Personalized Medicine (PM) Solution Sales Value, by Application (2020-2031)

4.2.3 Global Personalized Medicine (PM) Solution Sales Value, by Application (%) (2020-2031)

muLu

5 Segmentation by Region

5.1 Global Personalized Medicine (PM) Solution Sales Value by Region

5.1.1 Global Personalized Medicine (PM) Solution Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Personalized Medicine (PM) Solution Sales Value by Region (2020-2025)

5.1.3 Global Personalized Medicine (PM) Solution Sales Value by Region (2026-2031)

5.1.4 Global Personalized Medicine (PM) Solution Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Personalized Medicine (PM) Solution Sales Value, 2020-2031

5.2.2 North America Personalized Medicine (PM) Solution Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Personalized Medicine (PM) Solution Sales Value, 2020-2031

5.3.2 Europe Personalized Medicine (PM) Solution Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Personalized Medicine (PM) Solution Sales Value, 2020-2031

5.4.2 Asia Pacific Personalized Medicine (PM) Solution Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Personalized Medicine (PM) Solution Sales Value, 2020-2031

5.5.2 South America Personalized Medicine (PM) Solution Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Personalized Medicine (PM) Solution Sales Value, 2020-2031

5.6.2 Middle East & Africa Personalized Medicine (PM) Solution Sales Value by Country (%), 2024 VS 2031

muLu

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Personalized Medicine (PM) Solution Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Personalized Medicine (PM) Solution Sales Value, 2020-2031

6.3 United States

6.3.1 United States Personalized Medicine (PM) Solution Sales Value, 2020-2031

6.3.2 United States Personalized Medicine (PM) Solution Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Personalized Medicine (PM) Solution Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Personalized Medicine (PM) Solution Sales Value, 2020-2031

6.4.2 Europe Personalized Medicine (PM) Solution Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Personalized Medicine (PM) Solution Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Personalized Medicine (PM) Solution Sales Value, 2020-2031

6.5.2 China Personalized Medicine (PM) Solution Sales Value by Type (%), 2024 VS 2031

6.5.3 China Personalized Medicine (PM) Solution Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Personalized Medicine (PM) Solution Sales Value, 2020-2031

6.6.2 Japan Personalized Medicine (PM) Solution Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Personalized Medicine (PM) Solution Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Personalized Medicine (PM) Solution Sales Value, 2020-2031

6.7.2 South Korea Personalized Medicine (PM) Solution Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Personalized Medicine (PM) Solution Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Personalized Medicine (PM) Solution Sales Value, 2020-2031

6.8.2 Southeast Asia Personalized Medicine (PM) Solution Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Personalized Medicine (PM) Solution Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Personalized Medicine (PM) Solution Sales Value, 2020-2031

6.9.2 India Personalized Medicine (PM) Solution Sales Value by Type (%), 2024 VS 2031

6.9.3 India Personalized Medicine (PM) Solution Sales Value by Application, 2024 VS 2031

muLu

7 Company Profiles

7.1 2bPrecise

7.1.1 2bPrecise Profile

7.1.2 2bPrecise Main Business

7.1.3 2bPrecise Personalized Medicine (PM) Solution Products, Services and Solutions

7.1.4 2bPrecise Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.1.5 2bPrecise Recent Developments

7.2 OneOme

7.2.1 OneOme Profile

7.2.2 OneOme Main Business

7.2.3 OneOme Personalized Medicine (PM) Solution Products, Services and Solutions

7.2.4 OneOme Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.2.5 OneOme Recent Developments

7.3 TIGAR Health- IR2Dx

7.3.1 TIGAR Health- IR2Dx Profile

7.3.2 TIGAR Health- IR2Dx Main Business

7.3.3 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Products, Services and Solutions

7.3.4 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.3.5 TIGAR Health- IR2Dx Recent Developments

7.4 Kailos Genetics

7.4.1 Kailos Genetics Profile

7.4.2 Kailos Genetics Main Business

7.4.3 Kailos Genetics Personalized Medicine (PM) Solution Products, Services and Solutions

7.4.4 Kailos Genetics Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.4.5 Kailos Genetics Recent Developments

7.5 Syapse Inc

7.5.1 Syapse Inc Profile

7.5.2 Syapse Inc Main Business

7.5.3 Syapse Inc Personalized Medicine (PM) Solution Products, Services and Solutions

7.5.4 Syapse Inc Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.5.5 Syapse Inc Recent Developments

7.6 Karius

7.6.1 Karius Profile

7.6.2 Karius Main Business

7.6.3 Karius Personalized Medicine (PM) Solution Products, Services and Solutions

7.6.4 Karius Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.6.5 Karius Recent Developments

7.7 Astarte Medical

7.7.1 Astarte Medical Profile

7.7.2 Astarte Medical Main Business

7.7.3 Astarte Medical Personalized Medicine (PM) Solution Products, Services and Solutions

7.7.4 Astarte Medical Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.7.5 Astarte Medical Recent Developments

7.8 Fabric Genomics, INC.

7.8.1 Fabric Genomics, INC. Profile

7.8.2 Fabric Genomics, INC. Main Business

7.8.3 Fabric Genomics, INC. Personalized Medicine (PM) Solution Products, Services and Solutions

7.8.4 Fabric Genomics, INC. Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.8.5 Fabric Genomics, INC. Recent Developments

7.9 Orion Health

7.9.1 Orion Health Profile

7.9.2 Orion Health Main Business

7.9.3 Orion Health Personalized Medicine (PM) Solution Products, Services and Solutions

7.9.4 Orion Health Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.9.5 Orion Health Recent Developments

7.10 2B Precise

7.10.1 2B Precise Profile

7.10.2 2B Precise Main Business

7.10.3 2B Precise Personalized Medicine (PM) Solution Products, Services and Solutions

7.10.4 2B Precise Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.10.5 2B Precise Recent Developments

7.11 Fabric Genomics

7.11.1 Fabric Genomics Profile

7.11.2 Fabric Genomics Main Business

7.11.3 Fabric Genomics Personalized Medicine (PM) Solution Products, Services and Solutions

7.11.4 Fabric Genomics Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.11.5 Fabric Genomics Recent Developments

7.12 Pfizer

7.12.1 Pfizer Profile

7.12.2 Pfizer Main Business

7.12.3 Pfizer Personalized Medicine (PM) Solution Products, Services and Solutions

7.12.4 Pfizer Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.12.5 Pfizer Recent Developments

7.13 Gene 42

7.13.1 Gene 42 Profile

7.13.2 Gene 42 Main Business

7.13.3 Gene 42 Personalized Medicine (PM) Solution Products, Services and Solutions

7.13.4 Gene 42 Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.13.5 Gene 42 Recent Developments

7.14 IBM Watson Health

7.14.1 IBM Watson Health Profile

7.14.2 IBM Watson Health Main Business

7.14.3 IBM Watson Health Personalized Medicine (PM) Solution Products, Services and Solutions

7.14.4 IBM Watson Health Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.14.5 IBM Watson Health Recent Developments

7.15 Philips Healthcare

7.15.1 Philips Healthcare Profile

7.15.2 Philips Healthcare Main Business

7.15.3 Philips Healthcare Personalized Medicine (PM) Solution Products, Services and Solutions

7.15.4 Philips Healthcare Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.15.5 Philips Healthcare Recent Developments

7.16 Medtronic

7.16.1 Medtronic Profile

7.16.2 Medtronic Main Business

7.16.3 Medtronic Personalized Medicine (PM) Solution Products, Services and Solutions

7.16.4 Medtronic Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.16.5 Medtronic Recent Developments

7.17 Nanthealth

7.17.1 Nanthealth Profile

7.17.2 Nanthealth Main Business

7.17.3 Nanthealth Personalized Medicine (PM) Solution Products, Services and Solutions

7.17.4 Nanthealth Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.17.5 Nanthealth Recent Developments

7.18 Navican

7.18.1 Navican Profile

7.18.2 Navican Main Business

7.18.3 Navican Personalized Medicine (PM) Solution Products, Services and Solutions

7.18.4 Navican Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.18.5 Navican Recent Developments

7.19 N-of-One

7.19.1 N-of-One Profile

7.19.2 N-of-One Main Business

7.19.3 N-of-One Personalized Medicine (PM) Solution Products, Services and Solutions

7.19.4 N-of-One Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.19.5 N-of-One Recent Developments

7.20 PierianDx

7.20.1 PierianDx Profile

7.20.2 PierianDx Main Business

7.20.3 PierianDx Personalized Medicine (PM) Solution Products, Services and Solutions

7.20.4 PierianDx Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.20.5 PierianDx Recent Developments

7.21 Sunquest Information System

7.21.1 Sunquest Information System Profile

7.21.2 Sunquest Information System Main Business

7.21.3 Sunquest Information System Personalized Medicine (PM) Solution Products, Services and Solutions

7.21.4 Sunquest Information System Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.21.5 Sunquest Information System Recent Developments

7.22 Tempus

7.22.1 Tempus Profile

7.22.2 Tempus Main Business

7.22.3 Tempus Personalized Medicine (PM) Solution Products, Services and Solutions

7.22.4 Tempus Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.22.5 Tempus Recent Developments

7.23 Novartis

7.23.1 Novartis Profile

7.23.2 Novartis Main Business

7.23.3 Novartis Personalized Medicine (PM) Solution Products, Services and Solutions

7.23.4 Novartis Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.23.5 Novartis Recent Developments

7.24 Translational Software

7.24.1 Translational Software Profile

7.24.2 Translational Software Main Business

7.24.3 Translational Software Personalized Medicine (PM) Solution Products, Services and Solutions

7.24.4 Translational Software Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.24.5 Translational Software Recent Developments

7.25 Biocrates Life Sciences AG

7.25.1 Biocrates Life Sciences AG Profile

7.25.2 Biocrates Life Sciences AG Main Business

7.25.3 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Products, Services and Solutions

7.25.4 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.25.5 Biocrates Life Sciences AG Recent Developments

7.26 Nanostring Technologies

7.26.1 Nanostring Technologies Profile

7.26.2 Nanostring Technologies Main Business

7.26.3 Nanostring Technologies Personalized Medicine (PM) Solution Products, Services and Solutions

7.26.4 Nanostring Technologies Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.26.5 Nanostring Technologies Recent Developments

7.27 Thermo Fisher Scientific

7.27.1 Thermo Fisher Scientific Profile

7.27.2 Thermo Fisher Scientific Main Business

7.27.3 Thermo Fisher Scientific Personalized Medicine (PM) Solution Products, Services and Solutions

7.27.4 Thermo Fisher Scientific Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.27.5 Thermo Fisher Scientific Recent Developments

7.28 Quest Diagnostics Incorporated

7.28.1 Quest Diagnostics Incorporated Profile

7.28.2 Quest Diagnostics Incorporated Main Business

7.28.3 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Products, Services and Solutions

7.28.4 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Revenue (US$ Million) & (2020-2025)

7.28.5 Quest Diagnostics Incorporated Recent Developments

muLu

8 Industry Chain Analysis

8.1 Personalized Medicine (PM) Solution Industrial Chain

8.2 Personalized Medicine (PM) Solution Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Personalized Medicine (PM) Solution Sales Model

8.5.2 Sales Channel

8.5.3 Personalized Medicine (PM) Solution Distributors

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Personalized Medicine (PM) Solution Market Trends
Table 2. Personalized Medicine (PM) Solution Market Drivers & Opportunity
Table 3. Personalized Medicine (PM) Solution Market Challenges
Table 4. Personalized Medicine (PM) Solution Market Restraints
Table 5. Global Personalized Medicine (PM) Solution Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Personalized Medicine (PM) Solution Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Personalized Medicine (PM) Solution Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Personalized Medicine (PM) Solution Product Type
Table 9. Key Companies Time to Begin Mass Production of Personalized Medicine (PM) Solution
Table 10. Global Personalized Medicine (PM) Solution Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine (PM) Solution as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Personalized Medicine (PM) Solution Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Personalized Medicine (PM) Solution Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Personalized Medicine (PM) Solution Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Personalized Medicine (PM) Solution Sales Market Share in Value by Type (2020-2025)
Table 17. Global Personalized Medicine (PM) Solution Sales Market Share in Value by Type (2026-2031)
Table 18. Global Personalized Medicine (PM) Solution Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Personalized Medicine (PM) Solution Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Personalized Medicine (PM) Solution Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Personalized Medicine (PM) Solution Sales Market Share in Value by Application (2020-2025)
Table 22. Global Personalized Medicine (PM) Solution Sales Market Share in Value by Application (2026-2031)
Table 23. Global Personalized Medicine (PM) Solution Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Personalized Medicine (PM) Solution Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Personalized Medicine (PM) Solution Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Personalized Medicine (PM) Solution Sales Value by Region (2020-2025) & (%)
Table 27. Global Personalized Medicine (PM) Solution Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Personalized Medicine (PM) Solution Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Personalized Medicine (PM) Solution Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Personalized Medicine (PM) Solution Sales Value, (2026-2031) & (US$ Million)
Table 31. 2bPrecise Basic Information List
Table 32. 2bPrecise Description and Business Overview
Table 33. 2bPrecise Personalized Medicine (PM) Solution Products, Services and Solutions
Table 34. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of 2bPrecise (2020-2025)
Table 35. 2bPrecise Recent Developments
Table 36. OneOme Basic Information List
Table 37. OneOme Description and Business Overview
Table 38. OneOme Personalized Medicine (PM) Solution Products, Services and Solutions
Table 39. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of OneOme (2020-2025)
Table 40. OneOme Recent Developments
Table 41. TIGAR Health- IR2Dx Basic Information List
Table 42. TIGAR Health- IR2Dx Description and Business Overview
Table 43. TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Products, Services and Solutions
Table 44. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of TIGAR Health- IR2Dx (2020-2025)
Table 45. TIGAR Health- IR2Dx Recent Developments
Table 46. Kailos Genetics Basic Information List
Table 47. Kailos Genetics Description and Business Overview
Table 48. Kailos Genetics Personalized Medicine (PM) Solution Products, Services and Solutions
Table 49. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Kailos Genetics (2020-2025)
Table 50. Kailos Genetics Recent Developments
Table 51. Syapse Inc Basic Information List
Table 52. Syapse Inc Description and Business Overview
Table 53. Syapse Inc Personalized Medicine (PM) Solution Products, Services and Solutions
Table 54. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Syapse Inc (2020-2025)
Table 55. Syapse Inc Recent Developments
Table 56. Karius Basic Information List
Table 57. Karius Description and Business Overview
Table 58. Karius Personalized Medicine (PM) Solution Products, Services and Solutions
Table 59. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Karius (2020-2025)
Table 60. Karius Recent Developments
Table 61. Astarte Medical Basic Information List
Table 62. Astarte Medical Description and Business Overview
Table 63. Astarte Medical Personalized Medicine (PM) Solution Products, Services and Solutions
Table 64. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Astarte Medical (2020-2025)
Table 65. Astarte Medical Recent Developments
Table 66. Fabric Genomics, INC. Basic Information List
Table 67. Fabric Genomics, INC. Description and Business Overview
Table 68. Fabric Genomics, INC. Personalized Medicine (PM) Solution Products, Services and Solutions
Table 69. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Fabric Genomics, INC. (2020-2025)
Table 70. Fabric Genomics, INC. Recent Developments
Table 71. Orion Health Basic Information List
Table 72. Orion Health Description and Business Overview
Table 73. Orion Health Personalized Medicine (PM) Solution Products, Services and Solutions
Table 74. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Orion Health (2020-2025)
Table 75. Orion Health Recent Developments
Table 76. 2B Precise Basic Information List
Table 77. 2B Precise Description and Business Overview
Table 78. 2B Precise Personalized Medicine (PM) Solution Products, Services and Solutions
Table 79. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of 2B Precise (2020-2025)
Table 80. 2B Precise Recent Developments
Table 81. Fabric Genomics Basic Information List
Table 82. Fabric Genomics Description and Business Overview
Table 83. Fabric Genomics Personalized Medicine (PM) Solution Products, Services and Solutions
Table 84. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Fabric Genomics (2020-2025)
Table 85. Fabric Genomics Recent Developments
Table 86. Pfizer Basic Information List
Table 87. Pfizer Description and Business Overview
Table 88. Pfizer Personalized Medicine (PM) Solution Products, Services and Solutions
Table 89. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Pfizer (2020-2025)
Table 90. Pfizer Recent Developments
Table 91. Gene 42 Basic Information List
Table 92. Gene 42 Description and Business Overview
Table 93. Gene 42 Personalized Medicine (PM) Solution Products, Services and Solutions
Table 94. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Gene 42 (2020-2025)
Table 95. Gene 42 Recent Developments
Table 96. IBM Watson Health Basic Information List
Table 97. IBM Watson Health Description and Business Overview
Table 98. IBM Watson Health Personalized Medicine (PM) Solution Products, Services and Solutions
Table 99. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of IBM Watson Health (2020-2025)
Table 100. IBM Watson Health Recent Developments
Table 101. Philips Healthcare Basic Information List
Table 102. Philips Healthcare Description and Business Overview
Table 103. Philips Healthcare Personalized Medicine (PM) Solution Products, Services and Solutions
Table 104. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Philips Healthcare (2020-2025)
Table 105. Philips Healthcare Recent Developments
Table 106. Medtronic Basic Information List
Table 107. Medtronic Description and Business Overview
Table 108. Medtronic Personalized Medicine (PM) Solution Products, Services and Solutions
Table 109. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Medtronic (2020-2025)
Table 110. Medtronic Recent Developments
Table 111. Nanthealth Basic Information List
Table 112. Nanthealth Description and Business Overview
Table 113. Nanthealth Personalized Medicine (PM) Solution Products, Services and Solutions
Table 114. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Nanthealth (2020-2025)
Table 115. Nanthealth Recent Developments
Table 116. Navican Basic Information List
Table 117. Navican Description and Business Overview
Table 118. Navican Personalized Medicine (PM) Solution Products, Services and Solutions
Table 119. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Navican (2020-2025)
Table 120. Navican Recent Developments
Table 121. N-of-One Basic Information List
Table 122. N-of-One Description and Business Overview
Table 123. N-of-One Personalized Medicine (PM) Solution Products, Services and Solutions
Table 124. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of N-of-One (2020-2025)
Table 125. N-of-One Recent Developments
Table 126. PierianDx Basic Information List
Table 127. PierianDx Description and Business Overview
Table 128. PierianDx Personalized Medicine (PM) Solution Products, Services and Solutions
Table 129. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of PierianDx (2020-2025)
Table 130. PierianDx Recent Developments
Table 131. Sunquest Information System Basic Information List
Table 132. Sunquest Information System Description and Business Overview
Table 133. Sunquest Information System Personalized Medicine (PM) Solution Products, Services and Solutions
Table 134. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Sunquest Information System (2020-2025)
Table 135. Sunquest Information System Recent Developments
Table 136. Tempus Basic Information List
Table 137. Tempus Description and Business Overview
Table 138. Tempus Personalized Medicine (PM) Solution Products, Services and Solutions
Table 139. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Tempus (2020-2025)
Table 140. Tempus Recent Developments
Table 141. Novartis Basic Information List
Table 142. Novartis Description and Business Overview
Table 143. Novartis Personalized Medicine (PM) Solution Products, Services and Solutions
Table 144. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Novartis (2020-2025)
Table 145. Novartis Recent Developments
Table 146. Translational Software Basic Information List
Table 147. Translational Software Description and Business Overview
Table 148. Translational Software Personalized Medicine (PM) Solution Products, Services and Solutions
Table 149. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Translational Software (2020-2025)
Table 150. Translational Software Recent Developments
Table 151. Biocrates Life Sciences AG Basic Information List
Table 152. Biocrates Life Sciences AG Description and Business Overview
Table 153. Biocrates Life Sciences AG Personalized Medicine (PM) Solution Products, Services and Solutions
Table 154. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Biocrates Life Sciences AG (2020-2025)
Table 155. Biocrates Life Sciences AG Recent Developments
Table 156. Nanostring Technologies Basic Information List
Table 157. Nanostring Technologies Description and Business Overview
Table 158. Nanostring Technologies Personalized Medicine (PM) Solution Products, Services and Solutions
Table 159. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Nanostring Technologies (2020-2025)
Table 160. Nanostring Technologies Recent Developments
Table 161. Thermo Fisher Scientific Basic Information List
Table 162. Thermo Fisher Scientific Description and Business Overview
Table 163. Thermo Fisher Scientific Personalized Medicine (PM) Solution Products, Services and Solutions
Table 164. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Thermo Fisher Scientific (2020-2025)
Table 165. Thermo Fisher Scientific Recent Developments
Table 166. Quest Diagnostics Incorporated Basic Information List
Table 167. Quest Diagnostics Incorporated Description and Business Overview
Table 168. Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Products, Services and Solutions
Table 169. Revenue (US$ Million) in Personalized Medicine (PM) Solution Business of Quest Diagnostics Incorporated (2020-2025)
Table 170. Quest Diagnostics Incorporated Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. Personalized Medicine (PM) Solution Downstream Customers
Table 174. Personalized Medicine (PM) Solution Distributors List
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
Table 178. Business Unit and Senior & Team Lead Analysts
muLu

List of Figures

Figure 1. Personalized Medicine (PM) Solution Product Picture
Figure 2. Global Personalized Medicine (PM) Solution Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Personalized Medicine (PM) Solution Sales Value (2020-2031) & (US$ Million)
Figure 4. Personalized Medicine (PM) Solution Report Years Considered
Figure 5. Global Personalized Medicine (PM) Solution Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Personalized Medicine (PM) Solution Revenue in 2024
Figure 7. Personalized Medicine (PM) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Personalized Diagnostics Picture
Figure 9. Personalized Therapies Picture
Figure 10. Personalized Nutrition & Wellness Picture
Figure 11. Global Personalized Medicine (PM) Solution Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global Personalized Medicine (PM) Solution Sales Value Market Share by Type, 2024 & 2031
Figure 13. Product Picture of Oncology
Figure 14. Product Picture of Neurosciences
Figure 15. Product Picture of Immunology
Figure 16. Product Picture of Respiratory
Figure 17. Product Picture of Others
Figure 18. Global Personalized Medicine (PM) Solution Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 19. Global Personalized Medicine (PM) Solution Sales Value Market Share by Application, 2024 & 2031
Figure 20. North America Personalized Medicine (PM) Solution Sales Value (2020-2031) & (US$ Million)
Figure 21. North America Personalized Medicine (PM) Solution Sales Value by Country (%), 2024 VS 2031
Figure 22. Europe Personalized Medicine (PM) Solution Sales Value, (2020-2031) & (US$ Million)
Figure 23. Europe Personalized Medicine (PM) Solution Sales Value by Country (%), 2024 VS 2031
Figure 24. Asia Pacific Personalized Medicine (PM) Solution Sales Value, (2020-2031) & (US$ Million)
Figure 25. Asia Pacific Personalized Medicine (PM) Solution Sales Value by Region (%), 2024 VS 2031
Figure 26. South America Personalized Medicine (PM) Solution Sales Value, (2020-2031) & (US$ Million)
Figure 27. South America Personalized Medicine (PM) Solution Sales Value by Country (%), 2024 VS 2031
Figure 28. Middle East & Africa Personalized Medicine (PM) Solution Sales Value, (2020-2031) & (US$ Million)
Figure 29. Middle East & Africa Personalized Medicine (PM) Solution Sales Value by Country (%), 2024 VS 2031
Figure 30. Key Countries/Regions Personalized Medicine (PM) Solution Sales Value (%), (2020-2031)
Figure 31. United States Personalized Medicine (PM) Solution Sales Value, (2020-2031) & (US$ Million)
Figure 32. United States Personalized Medicine (PM) Solution Sales Value by Type (%), 2024 VS 2031
Figure 33. United States Personalized Medicine (PM) Solution Sales Value by Application (%), 2024 VS 2031
Figure 34. Europe Personalized Medicine (PM) Solution Sales Value, (2020-2031) & (US$ Million)
Figure 35. Europe Personalized Medicine (PM) Solution Sales Value by Type (%), 2024 VS 2031
Figure 36. Europe Personalized Medicine (PM) Solution Sales Value by Application (%), 2024 VS 2031
Figure 37. China Personalized Medicine (PM) Solution Sales Value, (2020-2031) & (US$ Million)
Figure 38. China Personalized Medicine (PM) Solution Sales Value by Type (%), 2024 VS 2031
Figure 39. China Personalized Medicine (PM) Solution Sales Value by Application (%), 2024 VS 2031
Figure 40. Japan Personalized Medicine (PM) Solution Sales Value, (2020-2031) & (US$ Million)
Figure 41. Japan Personalized Medicine (PM) Solution Sales Value by Type (%), 2024 VS 2031
Figure 42. Japan Personalized Medicine (PM) Solution Sales Value by Application (%), 2024 VS 2031
Figure 43. South Korea Personalized Medicine (PM) Solution Sales Value, (2020-2031) & (US$ Million)
Figure 44. South Korea Personalized Medicine (PM) Solution Sales Value by Type (%), 2024 VS 2031
Figure 45. South Korea Personalized Medicine (PM) Solution Sales Value by Application (%), 2024 VS 2031
Figure 46. Southeast Asia Personalized Medicine (PM) Solution Sales Value, (2020-2031) & (US$ Million)
Figure 47. Southeast Asia Personalized Medicine (PM) Solution Sales Value by Type (%), 2024 VS 2031
Figure 48. Southeast Asia Personalized Medicine (PM) Solution Sales Value by Application (%), 2024 VS 2031
Figure 49. India Personalized Medicine (PM) Solution Sales Value, (2020-2031) & (US$ Million)
Figure 50. India Personalized Medicine (PM) Solution Sales Value by Type (%), 2024 VS 2031
Figure 51. India Personalized Medicine (PM) Solution Sales Value by Application (%), 2024 VS 2031
Figure 52. Personalized Medicine (PM) Solution Industrial Chain
Figure 53. Personalized Medicine (PM) Solution Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Personalized Medicine (PM) Solution market?zhanKai
The top companies in the global Personalized Medicine (PM) Solution market are 2bPrecise、OneOme、TIGAR Health- IR2Dx.
den_biaoTiZhungShi

Related Reports

Personalized Medicine (PM) Solution- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-02-21

Pages: 166 Pages

Report ld: 4142554

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

SIMON LEE

+1-62 6295 2442

English,Chinese

Offline

HITESH

HITESH

+91-86 6998 6909

English, Hindi

Offline

TANG XIN

TANG XIN

+81-90 3800 9273

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

YUJIE TIAN

+86-135-2215-3954

Chinese, English

Online

DAMON

DAMON

+86-133 1872 9947

Chinese, English

Online

General Email:
global@qyresearch.com

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now